admelog

Generic: insulin lispro

Labeler: sanofi-aventis u.s. llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name admelog
Generic Name insulin lispro
Labeler sanofi-aventis u.s. llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

insulin lispro 100 U/mL

Manufacturer
Sanofi-Aventis U.S. LLC

Identifiers & Regulatory

Product NDC 0024-5926
Product ID 0024-5926_9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA209196
Listing Expiration 2026-12-31
Marketing Start 2018-10-19

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00245926
Hyphenated Format 0024-5926

Supplemental Identifiers

RxCUI
242120 1652639 1992169 1992171
UNII
GFX7QIS1II
NUI
N0000004931 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name admelog (source: ndc)
Generic Name insulin lispro (source: ndc)
Application Number BLA209196 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 U/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

insulin lispro (100 U/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5", "openfda": {"nui": ["N0000004931", "N0000175453"], "unii": ["GFX7QIS1II"], "rxcui": ["242120", "1652639", "1992169", "1992171"], "spl_set_id": ["0691def8-4a7b-4de3-866f-a280989f47f1"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0024-5926-05)  / 3 mL in 1 VIAL", "package_ndc": "0024-5926-05", "marketing_start_date": "20181019"}], "brand_name": "ADMELOG", "product_id": "0024-5926_9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [Chemical/Ingredient]"], "product_ndc": "0024-5926", "generic_name": "insulin lispro", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADMELOG", "active_ingredients": [{"name": "INSULIN LISPRO", "strength": "100 U/mL"}], "application_number": "BLA209196", "marketing_category": "BLA", "marketing_start_date": "20181019", "listing_expiration_date": "20261231"}